News

AUCKLAND, New Zealand – October 1, 2024: DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, commends Pharmac’s decision to fund continuous glucose monitors (CGM) and compatible insulin pumps and consumables for all New Zealanders living with Type 1 diabetes. Kirstin Brown, New Zealand Country Manager at Dexcom …

Continue reading "Dexcom celebrates funded access to life-changing diabetes technology for all New Zealanders with Type 1 diabetes"

AUCKLAND, New Zealand – 3 April 2024: Dexcom Inc. (Nasdaq: DXCM), is excited about Pharmac’s latest announcement today regarding the consultation process for Continuous Glucose Monitoring (CGM) and Insulin Pump funding in New Zealand – we are so close to people with T1D in NZ getting access to (CGM) systems! Kirstin Brown, Country Manager at …

Continue reading "Pharmac’s public consultation announcement is one step closer for Type 1 diabetes community"

In June 2022, New Zealand Medical & Scientific Ltd (NZMS) issued a product correction letter for Tandem Diabetes Care™ t:slim X2™ Insulin Pump. You can view this letter here. If your pump is running on software 6.4.1 or lower, follow the below instructions to update your pump. Updating your pump may take 15-30 minutes depending …

Continue reading "Software update for the t:slim X2 insulin pump"

AUCKLAND, New Zealand – 5 May 2023: Dexcom Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring for people with diabetes, and its New Zealand subsidiary New Zealand Medical and Scientific Ltd (NZMS Diabetes) are pleased to announce that the Dexcom G6 and Dexcom G7 Continuous Glucose Monitoring (CGM) systems are now compatible with selected …

Continue reading "Dexcom x Garmin Connectivity Announcement"

AUCKLAND, New Zealand – 15 April 2023: NZMS Diabetes, a  Dexcom Inc. (Nasdaq: DXCM) company, have announced a new partnership with Diabetes New Zealand to improve access and awareness to diabetes technology in New Zealand. The partnership will bring together the expertise and resources of both organisations to drive campaigns for improved access to diabetes …

Continue reading "Partnership with Diabetes New Zealand aims to improve access and awareness of diabetes within NZ"

AUCKLAND, New Zealand – 30 January 2023: Dexcom Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring for people with diabetes, and its New Zealand subsidiary New Zealand Medical and Scientific Ltd (NZMS Diabetes) have released a School Guide to give schools the information they need to better support students with Type 1 diabetes. The Guide aims …

Continue reading "School Guide To Raise Diabetes Awareness in Schools"

AUCKLAND, New Zealand – 20 January 2023: NZMS Diabetes are proud to support community-based organisation No More Fear NZ with their efforts to empower the type 1 diabetes community in New Zealand. The organisation founded by Lavina Good and son, Toby, passionately advocates for all New Zealanders living with type 1 diabetes, a condition close …

Continue reading "NZMS Diabetes supports community-based organisation @NoMoreFearNZ in spotlighting the type 1 diabetes community"

AUCKLAND, New Zealand – 10 November 2022: In time for World Diabetes Day and as part of Diabetes Action Month, Dexcom Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring for people with diabetes, and its New Zealand subsidiary New Zealand Medical and Scientific Ltd (NZMS) Diabetes today announced the arrival of the …

Continue reading "World Diabetes Day Marks 3 Inspirational Kiwis Joining Dexcom Warriors Advocacy Movement To New Zealand In 2023"

New Zealand first in the southern hemisphere to launch Dexcom G7 Continuous Glucose Monitoring System to improve diabetes management for Kiwis Latest technology becomes available as November marks World Diabetes Day and New Zealand Diabetes Action Month AUCKLAND, New Zealand – Thursday Oct. 27, 2022 – Dexcom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous …

Continue reading "NZMS Diabetes Launches the next-generation Dexcom CGM, Dexcom G7!"

April 2022 – NZMS Diabetes is excited to announce the launch of Control-IQ™ technology for the t:slim X2™ insulin pump! The t:slim X2 insulin pump (compatible with Dexcom G6 continuous glucose monitoring) is capable of remote feature updates.* Recently, we welcomed the newest software to launch within New Zealand; Control-IQ. Control-IQ technology is an advanced …

Continue reading "Control-IQ Technology for the t:slim X2 Insulin Pump Launches in New Zealand"

With our longstanding support for New Zealanders living with Type 1 diabetes, we are extremely pleased to share that PHARMAC is undertaking a review on CGM funding, following a recommendation by the PTAC Diabetes Subcommittee that the Dexcom G6 CGM system be listed on the Pharmaceutical Schedule with high priority. This review acknowledges the value …

Continue reading "PHARMAC undertakes a review on funding for Dexcom G6 CGM technology"

As of the 24th January, NZMS Diabetes will discontinue the sale of Sensor, Transmitters and Receivers for the Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) System directly from NZMS Diabetes. The Dexcom G5 Mobile app will no longer be available to download from any device within New Zealand. We want our customers to experience the …

Continue reading "APAC – G5 App Obsolescence"

We are thrilled to bring you an update to the Dexcom G6 app! Designed to improve the user’s experience, this update (v1.9.0) affects all customers who are using Dexcom G6 CGM. The 1.9.0 update allows you, as a Dexcom G6 customer, to access a number of new and improved features, such as: An increase in the …

Continue reading "Dexcom unveils update for Dexcom G6 App with New and Improved Features"

Revolutionary new CGM system eliminates routine fingerpricks* for people with diabetes and is nearly one-third slimmer than previous generation  Update 04.05.2020 NZMS Diabetes is excited to announce the powerful and revolutionary Dexcom G6 Continuous Glucose Monitoring System (CGM) will be available in New Zealand for people with diabetes ages 2 years and up beginning in …

Continue reading "Dexcom G6 CGM available in New Zealand from Monday 11 May 2020"

Auckland, New Zealand, April 2019 NZMS Diabetes are delighted to announce that they have agreed to distribute MedAngel products.                                                                           …

Continue reading "NZMS Diabetes to distribute MedAngel ONE"

Auckland, NZ, April 2018 NZMS Diabetes announces distribution agreement with Valeritas Holdings, Inc.                                                                             NZMS Diabetes are pleased to …

Continue reading "Valeritas Holdings Partnership Announcement"

Auckland, New Zealand, April 2018 Revolutionary t:slim X2™ Insulin Pump from Tandem Diabetes Care® coming to New Zealand patients NZMS Diabetes announce a new partnership with Tandem Diabetes Care to introduce the t:slim X2™ Insulin Pump to New Zealand. NZMS Diabetes are delighted to announce they have partnered with Tandem Diabetes Care®, Inc. to introduce …

Continue reading "Tandem Diabetes Care Partnership Announcement"